Published in the Jan. 19 edition of JAMA, this article from KFF Executive Vice President for Health Policy Larry Levitt lays out the major health policy challenges that will confront President-elect Biden and potential approaches to major reform. While a big reform debate may not be likely this year, one…
- view as grid
- view as list
In his latest Axios column, Drew Altman looks at the challenge of vaccine hesitancy in rural America and its implications. One of them: a highly tailored outreach campaign is needed. “Addressing this hesitancy will require convincing rural Americans about the seriousness of the pandemic, and then that the vaccine is a way to protect them, their families and their way of life,” he said.
In this column for the JAMA Health Forum, Larry Levitt explores what President-elect Biden might do to advance his health care vision both through legislation and through executive orders and waivers and demonstrations.
Drew Altman’s Axios column draws on data from the new KFF COVID-19 Vaccine Monitor to assess where the country stands on vaccine hesitancy.
In this Foreign Affairs article, Josh Michaud and Jen Kates lay out the challenges in vaccinating people in low-income countries around the world and review early plans to ensure safe and effective vaccines are made available and delivered to people across the globe.
New analysis from Drew Altman in his latest Axios column on the impact of the coronavirus pandemic on national health spending.
Drew Altman analyzes the exit polls in his latest Axios column. While Biden voters see COVID-19 as a top priority, Trump supporters are still largely pandemic deniers, echoing the President.
In this post, Ashley Kirzinger and Mollyann Brodie examine how the COVID-19 pandemic and other crises shook up the mix of issues voters care about without changing the 2020 presidential race’s core dynamic as a referendum on President Trump’s first term in office.
In an Axios column, Drew Altman discusses how this election year health isn’t a single issue — but several — and Joe Biden has the edge over President Trump on all of them, even as opposition to the ACA remains popular with Trump’s base.
Drew Altman discusses how systemic racism has led to striking levels of reluctance to get a COVID-19 vaccine among Black Americans, including those at highest risk, and the challenge it presents for ending the pandemic.